Endocrine

Hypothyroidism due to TSH receptor mutations

0

studies recruiting now

as of 7 Sept 2026

1

studies registered in total

as of 7 Sept 2026

0

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No recruiting trial found right now.

1 study is registered for Hypothyroidism due to TSH receptor mutations, but none was recruiting as of 7 Sept 2026. Here is what is still worth doing.

Keep watching

Get an email when a new Hypothyroidism due to TSH receptor mutations study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Hypothyroidism due to TSH receptor mutations

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (TSHR).

Treatments being studied

10 approved treatments and 1 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: LevothyroxineApproved: Cholestyramine (Cholestyramine)Approved: Omega-3-Acid Ethyl Esters (Dualtis)Approved: Liothyronine Sodium (Cynomel)Approved: Mecasermin (Bio-fd&c igf1)Approved: Fenofibrate (Antara)Approved: LiothyronineApproved: Thyroglobulin (Proloid)Approved: Levothyroxine Sodium (Eltroxin)Approved: Thyrotropin (Thytropar)
Phase 2/3Thyroid (Nature)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).